SCHEMBL25329758

SCHEMBL25329758

CC(C)Cc1cccc2c1nc(Cn1cccc(NC(=O)C(CC/C=C/C(N)=O)NC(=O)OC3CCOC3)c1=O)n2C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25329747 1.00 MAP4K1 (0.53) MAP4K1
SCHEMBL21684232 0.93 MAP4K1 (0.58) MAP4K1
SCHEMBL21684234 0.93 MAP4K1 (0.58) MAP4K1
SCHEMBL30467391 0.93 MAP4K1 (0.58) MAP4K1
SCHEMBL25328591 0.93 MAP4K1 (0.49) MAP4K1
SCHEMBL25328596 0.93 MAP4K1 (0.49) MAP4K1
SCHEMBL25328082 0.91 MAP4K1 (0.50) MAP4K1
SCHEMBL25328072 0.91 MAP4K1 (0.50) MAP4K1
SCHEMBL21683652 0.89 MAP4K1 (0.63) MAP4K1
SCHEMBL21683653 0.89 MAP4K1 (0.63) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed